303 related articles for article (PubMed ID: 26601797)
1. Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW;
Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797
[TBL] [Abstract][Full Text] [Related]
2. Drug- and herb-induced liver injury: a case series from a single center.
Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A
Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129
[TBL] [Abstract][Full Text] [Related]
3. Systematic review: ibuprofen-induced liver injury.
Zoubek ME; Lucena MI; Andrade RJ; Stephens C
Aliment Pharmacol Ther; 2020 Mar; 51(6):603-611. PubMed ID: 31984540
[TBL] [Abstract][Full Text] [Related]
4. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study.
Gulmez SE; Unal US; Lassalle R; Chartier A; Grolleau A; Moore N
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1174-1181. PubMed ID: 30112779
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations.
Bonkovsky HL; Ghabril M; Nicoletti P; Dellinger A; Fontana RJ; Barnhart H; Gu J; Daly AK; Aithal GP; Phillips EJ; Kleiner DE;
Liver Int; 2024 Jun; 44(6):1409-1421. PubMed ID: 38451034
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
Russo MW; Hoofnagle JH; Gu J; Fontana RJ; Barnhart H; Kleiner DE; Chalasani N; Bonkovsky HL
Hepatology; 2014 Aug; 60(2):679-86. PubMed ID: 24700436
[TBL] [Abstract][Full Text] [Related]
7. [NSAID-induced hepatotoxicity: aceclofenac and diclofenac].
Zaragoza Marcet A; Alfonso Moreno V; Roig Catalá E
Rev Esp Enferm Dig; 1995 Jun; 87(6):472-5. PubMed ID: 7612373
[TBL] [Abstract][Full Text] [Related]
8. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
9. Serious liver injury induced by Nimesulide: an international collaborative study.
Bessone F; Hernandez N; Mendizabal M; Ridruejo E; Gualano G; Fassio E; Peralta M; Fainboim H; Anders M; Tanno H; Tanno F; Parana R; Medina-Caliz I; Robles-Diaz M; Alvarez-Alvarez I; Niu H; Stephens C; Colombato L; Arrese M; Reggiardo MV; Ono SK; Carrilho F; Lucena MI; Andrade RJ
Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010
[TBL] [Abstract][Full Text] [Related]
10. How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.
Laine L; Goldkind L; Curtis SP; Connors LG; Yanqiong Z; Cannon CP
Am J Gastroenterol; 2009 Feb; 104(2):356-62. PubMed ID: 19174782
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
12. Presentation and outcomes with clinically apparent interferon beta hepatotoxicity.
Fontana RJ; Hayashi P; Bonkovsky HL; Kleiner DE; Kochhar S; Gu J; Ghabril M
Dig Dis Sci; 2013 Jun; 58(6):1766-75. PubMed ID: 23377559
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
Lacroix I; Lapeyre-Mestre M; Bagheri H; Pathak A; Montastruc JL; ;
Fundam Clin Pharmacol; 2004 Apr; 18(2):201-6. PubMed ID: 15066135
[TBL] [Abstract][Full Text] [Related]
15. [Diclofenac induced liver injuries].
Nezic L; Krähenbühl S; Rätz Bravo AE
Praxis (Bern 1994); 2012 Mar; 101(6):371-9. PubMed ID: 22419135
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drug-induced hepatoxicity.
Unzueta A; Vargas HE
Clin Liver Dis; 2013 Nov; 17(4):643-56, ix. PubMed ID: 24099022
[TBL] [Abstract][Full Text] [Related]
17. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
Chalasani N; Bonkovsky HL; Fontana R; Lee W; Stolz A; Talwalkar J; Reddy KR; Watkins PB; Navarro V; Barnhart H; Gu J; Serrano J;
Gastroenterology; 2015 Jun; 148(7):1340-52.e7. PubMed ID: 25754159
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
Siramolpiwat S; Sakonlaya D
Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
[TBL] [Abstract][Full Text] [Related]
20. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
